5 Key Takeaways
-
1
BVI Medical's Leos Laser has received FDA 510(k) clearance for treating early-stage glaucoma.
-
2
The Leos system lowers intraocular pressure through a minimally invasive ab interno procedure.
-
3
It combines laser endoscopy with enhanced visualization to improve glaucoma treatment.
-
4
The device integrates into standard surgical workflows and simplifies endoscopic cyclophotocoagulation.
-
5
A full US commercial launch of the Leos system is anticipated later this year.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.